Jeffrey Williams, MD
Cardiovascular Disease · Fort Myers, FLNPI 1518188861
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,025 of the $23,697 with a category attached, or 67.6%. Boston Scientific accounts for 89.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $6,772 and has fallen 90.9% since, to $614 in 2025. Among cardiovascular disease clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $282.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$21K
- Altathera Pharmaceuticals LLC$2K
- Abbott$215
- Elutia, Inc.$97
- AstraZeneca$80
- Pfizer$77
- plus $72 from 3 others
What the payments were for
- Consulting fees$16,02568%
- Speaking & faculty fees$4,60019%
- Travel & lodging$6913%
- Food & beverage$2,38110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 35 | $21,115 |
| Altathera Pharmaceuticals LLC | 2 | $2,040 |
| Abbott | 29 | $215 |
| Elutia, Inc. | 5 | $97 |
| AstraZeneca | 6 | $80 |
| Pfizer | 4 | $77 |
| Biotronik Inc. | 1 | $43 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$17,883
- Sotalol Hydrochloride$2,040
How this compares
$23,697 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Fort Myers
- Malissa WoodFort Myers$250K
- Michael LipinskiFort Myers$247K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.